Filing Impact
Filing Sentiment
Form Type
144
Sight Sciences, Inc.
Jan 13, 2026
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
Nov 6, 2025
Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
310.36M
41.91M
20.66%
50.37%
1.99%
Medical Devices
Surgical & Medical Instruments & Apparatus
United States
MENLO PARK